Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

Penumbra has announced US Food and Drug Administration approval for its Ruby XL system, which includes three coils: the Ruby ...

Nurse practitioners are increasingly filling a gap that is expected to widen as the senior population explodes and the number ...

Global Peripheral Artery Disease Market is valued at approximately USD 4.5 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2024-2032.

Increasing physician burnout, insurers denying reimbursements and delays in cardiovascular care are three aspects of cardiology that are making physicians and leaders nervous. These three ...

Sleeping on your back may have benefits for your skin and face. Learn what research says or doesn’t say and any drawbacks.

Pensioners with certain health conditions could be entitled to receive up to £441 a month in cash support. These disabilities ...

Penumbra's AI-guided aspiration system and scalable platform uniquely position it as a leader in stroke and PE intervention.

Mehrad Asadi Eidivand was arrested in May by agents outside his home in Phoenix and has been held in an ICE detention ...